• Last Updated 16:00:00 Jun 28, 2016

Start Guide
MENU

KEY DRIVERS Get Embed Code

Net Sales Growth20%
Innovative Products Sales Growth 28%
GIP Sales Growth25%

SIGNUP FOR BETA ACCESS

TO UNLOCK KEY DRIVERS

OPERATING SALES

SIGNUP FOR BETA ACCESS

TO UNLOCK FULL SEGMENT DATA

Trading Metrics Get Embed Code

50-Day Moving Average $33.93
200-Day Moving Average $32.30
Average Daily Volume (30-Day) 29.1 M
Market Beta 0.83
Year-to-Date Price Change 4.7%
1-Year Price Change 0.6%
Short Interest 1%
Days to Cover 1.9

GUIDANCE

Revenue Guidance FY-16$51.0 - $53.0 B
R&D Expense Guidance FY-16$7.4 - $7.8 B
Non-Adjusted EPS Guidance FY-16$1.72 - $1.85

DEBT & Liquidity

$39.4 B Total Debt

$2.56 B Total Cash

62.2% Debt/Equity

24.2% Debt/Assets

Summary

PFE

Pfizer, Inc. is a research-based, global biopharmaceutical company, which engages in the manufacture of vaccines and injectable biologic medicines. It operates through the following segments: Global Innovative... +

235 East 42nd Street
New York New York

Website | Map

CEO

Ian C. Read

Founded in

1849

Employees

97,900

Revenue/Employee

$0.52 m

IPO Date

June 22, 1942

Fiscal Year Ends

FY16 - Dec 31, 2016

Sector

Healthcare

Industry

Pharmaceuticals

QUARTERLY
Revenue$13 B
Revenue Growth19.7%
EPS$0.49
EPS Growth29%

SIGNUP FOR BETA ACCESS

TO UNLOCK ANNUAL DATA

1.44 Current Ratio

0.09 Cash Ratio

1.83% ROAA

4.72% ROAE

29.7% Operating Margin

81.1% Gross Margin

23.3% Net Income Margin

29% EPS Growth

Dividends & Splits

$0.3 Dividend Per Share

0.00% Dividend Yield

100.6% Payout Ratio

2016-02-03 Ex-Dividend Date

VALUATION PEERS Get Embed Code

  • Company

  • Change

  • P/E

  • P/S

  • P/BOOK

  • EV

  • PFE

  • +1.9%

  • 25.0

  • 3.7

  • 3.3

  • $207 B

  • AGN

  • +4.7%

  • NA

  • NA

  • NA

  • NA

  • MRK

  • +0.5%

  • NA

  • NA

  • NA

  • NA

  • JNJ

  • +1.4%

  • NA

  • NA

  • NA

  • NA

OUR DATA PARTNERS

  • MARKET DATA PROVIDED BY

  • FUNDAMENTALS AND METRICS COMPILED BY

  • CHARTING APIs PROVIDED BY